Search results
CVS Health ( CVS) is expected to report earnings on Wednesday, May 8, 2024. The stock is up 6.4% since its last earnings release, including a Post-earnings Announcement Drift (PEAD) of 6.4%. Calendar
- Fourth Quarter Highlights
- Full Year Highlights
- 2023 Full-Year Guidance
- CEO Commentary
- 2022 in The Spotlight
- Contacts
- Consolidated Fourth Quarter and Full-Year Results
- Teleconference and Webcast
- About Cvs Health
Total revenues increased to $83.8 billion, up 9.5% compared to prior yearGAAP diluted EPS of $1.75 and Adjusted EPS of $1.99Total revenues increased to $322.5 billion, up 10.4% compared to prior yearGAAP diluted EPS of $3.14 and Adjusted EPS of $8.69Generated cash flow from operations of $16.2 billionRepaid $4.1 billion of long-term debtGAAP diluted EPS guidance range of $7.73 to $7.93Adjusted EPS guidance range of $8.70 to $8.90Cash flow from operations guidance range of $12.5 billion to $13.5 billion“Last year was defined by outperformance across our foundational businesses, robust cash flow from operations and meaningful progress against our value-based care delivery strategy. 2022 was a year of progress, and we continue to build on that momentum with bold moves that will improve the health care experience.” — Karen S. Lynch, CVS Health Presi...
Entered into a definitive agreement to acquire Signify Health, a leader in home Health Risk Assessments, value-based care and provider enablement with a network of more than 10,000 clinicians acros...Announced a 10% increase to the quarterly shareholder dividend, which became effective with the February 1, 2023 dividend distribution. Returned $2.9 billion to shareholders through dividends, whil...Increased unique digital customers by seven million to over 47 million, reached eight million active users on CVS Health’s individualized Health Dashboard and interacted with nearly five million cu...Deepened our executive bench with several key appointments, including Dr. Amar Desai as President, Health Care Delivery and Tilak Mandadi as Executive Vice President and Chief Data, Digital and Tec...Investor contact
Larry McGrath Senior Vice President, Business Development and Investor Relations 800-201-0938
Media contact
T.J. Crawford Vice President, External Affairs 212-457-0583 The Company presents both GAAP and non-GAAP financial measures in this press release to assist in the comparison of the Company’s past financial performance with its current financial performance. See “Non-GAAP Financial Information” beginning on page 13 and endnotes beginning on page 25 for explanations of non-GAAP financial measures presented in this press release. See pages 15 through 16 and page 24 for reconciliations of each non...
For the three months and year ended December 31, 2022 compared to the prior year: 1. Total revenues increased 9.5% and 10.4%, respectively, driven by growth across all segments. 2. Operating income increased 62.3% in the three months ended December 31, 2022 compared to the prior year primarily due to the absence of a store impairment charge of appr...
The Company will be holding a conference call today for investors at 8:00 a.m. (Eastern Time) to discuss its fourth quarter and full-year results. An audio webcast of the call will be broadcast simultaneously for all interested parties through the Investor Relations section of the CVS Health website at http://investors.cvshealth.com. This webcast w...
CVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. Wherever and whe...
WOONSOCKET, R.I., Feb. 7, 2024 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months and year ended December 31, 2023. FOURTH QUARTER HIGHLIGHTS. Total revenues increased to $93.8 billion, up 11.9% compared to prior year. GAAP diluted EPS of $1.58 and Adjusted EPS of $2.12. KEY FINANCIAL DATA.
Jul 26, 2023 · Zacks Consensus Estimate. This drugstore chain and pharmacy benefits manager is expected to post quarterly earnings of $2.12 per share in its upcoming report, which represents a year-over-year...
Feb 8, 2023 · Q4 2022 Earnings Results. February 8, 2023 08:00 AM ET. Listen to webcast. Oak St. Health Investor Presentation. Listen to Webcast Q4 2022 Earnings Release Q4 2022 Earnings Presentation Q4 2022 Transcript Q4 2022 Form 10-K Q4 2022 Non-GAAP Reconciliation. 2022 ESG Report.
Apr 27, 2022 · Zacks Consensus Estimate. This drugstore chain and pharmacy benefits manager is expected to post quarterly earnings of $2.14 per share in its upcoming report, which represents a year-over-year...
11.02.22. WOONSOCKET, R.I., Nov. 2, 2022 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended September 30, 2022. THIRD QUARTER RESULTS. Total revenues increased to $81.2 billion, up 10.0% compared to prior year.